# Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo

> **NCT04349956** · — · TERMINATED · sponsor: **Unity Biotechnology, Inc.** · enrollment: 161 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** UBX0101 or placebo

## Key facts

- **NCT ID:** NCT04349956
- **Lead sponsor:** Unity Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-20
- **Primary completion:** 2020-11-02
- **Final completion:** 2020-11-02
- **Target enrollment:** 161 (ACTUAL)
- **Why stopped:** Inability to achieve primary or secondary study objectives
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349956, "Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04349956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*